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Genome-wide association study identiﬁes multiple
susceptibility loci for craniofacial microsomia
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Craniofacial microsomia (CFM) is a rare congenital anomaly that involves immature
derivatives from the ﬁrst and second pharyngeal arches. The genetic pathogenesis of CFM is
still unclear. Here we interrogate 0.9 million genetic variants in 939 CFM cases and 2,012
controls from China. After genotyping of an additional 443 cases and 1,669 controls, we
identify 8 signiﬁcantly associated loci with the most signiﬁcant SNP rs13089920 (logistic
regression P¼ 2.15 10 120) and 5 suggestive loci. The above 13 associated loci, harboured
by candidates of ROBO1, GATA3, GBX2, FGF3, NRP2, EDNRB, SHROOM3, SEMA7A, PLCD3,
KLF12 and EPAS1, are found to be enriched for genes involved in neural crest cell (NCC)
development and vasculogenesis. We then perform whole-genome sequencing on 21 samples
from the case cohort, and identify several novel loss-of-function mutations within the
associated loci. Our results provide new insights into genetic background of craniofacial
microsomia.
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C
raniofacial microsomia (CFM, MIM: 164210) encapsulates
congenital anomalies of the external and middle ear,
maxilla, mandible, facial and trigeminal nerves, and
surrounding soft tissues on the affected side1. The occurrence
of CFM is between 1 in 3,000 and 1 in 5,600 living births2.
Popular assumptions for the pathogenesis of CFM include neural
crest cell (NCC) disturbance and vascular disruption3. The NCCs
originate from the neural ectoderm, migrate over long distances
to participate in the formation of the ﬁrst and second pharyngeal
arches, and give raise to craniofacial structures4. Mouse models
have indicated that dysfunctional genes involved in NCCs
delamination, proliferation, migration or reciprocal interactions
with other cell types in pharyngeal arches would cause
impairments of the craniofacial development5. Through
vascular disruption during the morphogenesis of the
craniofacial vascular system6, localized ischaemia has been
considered as another risk factor for CFM, although this notion
is debatable7.
Many studies have revealed that CFM is caused by inherited
and/or environmental factors3,8,9. Genetic variants are largely
believed to contribute to this anomaly. Despite that various CFM
candidate genes were proposed from mouse models or human
syndromes with CFM3, to date, very few genetic variants have
been identiﬁed and validated in human.
To ﬁll in gaps in our knowledge about CFM and to decipher its
genetic basis, we perform the ﬁrst genome-wide association study
(GWAS) along with whole-genome sequencing (WGS) in CFM
patients from China. We ﬁnd eight signiﬁcant and ﬁve implicated
loci associated with CFM. Functional analyses on these loci
identify multiple CFM candidate genes involved in NCC
development.
Results
Basic GWAS results. For discovery, we conducted a GWAS in
939 CFM cases and 2,012 healthy controls from China, by testing
single-nucleotide polymorphisms (SNPs) that satisﬁed quality
control (792,342), with or without stratiﬁcations on subgroups of
gender and (left- versus right-) side-affected CFM. We then
evaluated the signiﬁcant SNPs with a P value o1 10 5 from
the discovery stage in validation set of 443 cases and 1,669
controls from China.
Logistic regression (LR) analyses on the two combined sample
sets identiﬁed seven genome-wide signiﬁcantly (Po6.3 10 8,
the Bonferroni-corrected signiﬁcance threshold) associated loci
with lead SNPs of rs13089920 (LR P¼ 2.15 10 120, odds ratio
(OR)¼ 5.18), rs10459648 (LR P¼ 2.86 10 23, OR¼ 0.63),
rs17802111 (LR P¼ 9.57 10 18, OR¼ 1.48), rs11263613 (LR
P¼ 7.91 10 17, OR¼ 1.68), rs3754648 (LR P¼ 6.33 10 13,
OR¼ 1.39), rs7420812 (LR P¼ 6.74 10 10, OR¼ 1.33), and
rs10905359 (LR P¼ 5.11 10 9, OR¼ 0.76; Fig. 1, Table 1). In
addition, ﬁve implicated loci with lead SNPs of rs3923380,
rs754423, rs4750407, rs9574113 and rs7222240, reached a
suggestive genome-wide signiﬁcance level (LR Po1 10 5;
Table 1, Supplementary Fig. 1). LR analyses on the subgroups
of CFM on gender and affected-side identiﬁed a signiﬁcant
associated locus with a leading SNP of rs17090300 (LR P¼ 1.04
 10 11, OR¼ 2.31) to left-side-affected CFM patients (n¼ 481;
Supplementary Fig. 2). The signiﬁcant heterogeneity of
association pattern (Cochran’s Q-test P¼ 2.09 10 6) was
found between the left- and right-side-affected subgroups at
rs17090300 (Supplementary Table 1). The phenotypic variance
explained by the signiﬁcantly associated and implicated lead SNPs
were 6.92% and 1.96%, respectively, with a prevalence rate of 1.4
per 10,000 in China10. Furthermore, the joint effect of all the
792,342 genotyped SNPs could explain 28.4% of the variance
observed in this study.
Imputation followed by conditional and joint analyses. To
identify additional associated variants, we imputed the untyped
variants from genotyping data and the haplotype information
provided by the 1000 Genomes Project (1KG). Among
the imputed variants, we identiﬁed 68 additional SNPs
(LR Po1 10 5) associated with CFM risk in the 13 associated
loci (7 signiﬁcant, 1 left-side speciﬁc, and 5 suggestive loci,
Supplementary Data 1). To assess whether the 68 SNPs were
independent from our initially identiﬁed leading SNPs,
we performed conditional analyses on the genotyped and
imputed variants. We did not ﬁnd any other independently
associated variants (Supplementary Fig. 3). To identify other
new loci associated with CFM, we used multiple regression
(by Wu et al.11) to test for the joint effect of the variants from a
gene or haplotype block. We were able to replicate some of the
identiﬁed loci, and did not ﬁnd additional associated ones
(Supplementary Table 2). Thus, no more new associated variants
or loci were identiﬁed in conditional and joint analyses.
Functional annotation and eQTL analysis. Functional non-
coding variants within gene regulatory elements may potentially
result in a disease phenotype through modulating gene expression
level. To predict the effects of variants on gene expression, we
submitted 291 SNPs (including 151 imputed SNPs) with a P value
o1 10 4 to SeattleSeq Annotation 138 and HaploReg (v2) for
analyses12. We found six SNPs located in known transcription
factor-binding sites (TFBS), and three of them (GWAS
Po6.3 10 8) located near or within ROBO1 (rs147642420),
KLF12 (rs7986825) or ARID3B (rs7497036) (Supplementary Data
2). Among the HaploReg annotated variants, 187 SNPs were
located in gene expression regulatory motifs, such as the
enhancers, promoters, open chromatins and protein-binding
sites (Supplementary Data 3). For enrichment analyses of cell
type-speciﬁc enhancers and DNase hypersensitive sites, we
conducted queries in HaploReg with the 291 SNPs and their
linked SNPs (r2¼ 1), based on the epigenomic data from
ENCODE or Roadmap. As for ENCODE data, these SNPs were
enriched in the enhancers or DNase hypersensitive sites of
eight cell lines (Supplementary Data 3), noting that the fold
change from observed to expected ‘strongest enhancer’ was 15.6
(binomial test Po1 10 6) in H1 embryonic stem cells.
As for Roadmap data, these SNPs were signiﬁcantly (w2-test
P¼ 1.3 10 4) enriched in the enhancers of stem cells and stem
cell-derived cell lines (Supplementary Fig. 4).
To conﬁrm the relations between CFM-associated SNPs and
gene expression, we used Genevar to map the expression
quantitative trait loci (eQTL) by correlating the SNPs with gene
expression levels in lymphoblastoid from HapMap populations13.
We found that several lead SNPs or their linked variants (r240.8,
calculated from Asian populations of 1KG) had nominal
associations (Po0.05) with the expression levels of the nearest
genes (Supplementary Data 4), such as ROBO1 (rs4401330,
linear regression P¼ 9.2 10 3, in CHB), KLF12 (rs7986825,
linear regression P¼ 8.8 10 3, in GIH), EDNRB (rs5351, linear
regression P¼ 5.1 10 3, in YRI) and SHROOM3 (rs4859453,
linear regression P¼ 2.0 10 3, in JPT). We then looked into
the regulatory function of these nominal cis-eQTLs and found
that 63% of them were located within the promoters, enhancers,
DNase hypersensitive sites or TFBS (Supplementary Data 5).
Enrichment analyses for these regulatory elements showed that
embryonic cells, epithelial cells and carcinoma cells were
signiﬁcantly enriched for those ‘strongest enhancers’ or DNase
hypersensitivity sites.
Pathway analyses. To identify the CFM candidate genes from the
13 associated loci and their potential connections, we used Gene
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Relationships Across Implicated Loci (GRAIL) methods14 to
analyse the 46 genes within the 13 associated loci (Supplementary
Data 6). Overall, 13 candidate genes were identiﬁed by GRAIL as
follows: ROBO1, GATA3, EPAS1, PARD3B, GBX2, SHROOM3,
FRMD4A, FGF3, KLF12, EDNRB, NID2, SEMA7A and PLCD3.
The pairwise relationships for the genes in the associated loci are
illustrated in Supplementary Fig. 5. In particular, this ﬁgure
highlights that genes involved in embryonic development, such as
ROBO1, NRP2, GBX2, FGF3, PARD3B, SEMA7A and SHROOM3,
are closely connected. Also, ROBO1, NRP2, GBX2, FGF3 and
SEMA7A are involved in signalling pathways that regulate the
migration of NCCs.
To investigate the enrichment of functional annotation, we
used Database for Annotation, Visualization and Integrated
Discovery (DAVID)15 to examine the 46 genes from the GRAIL
analysis. The functional annotation clustering results are provided
in Supplementary Data 7. Four DAVID-deﬁned clusters
displayed signiﬁcant enrichment scores (ES) (Fisher’s exact
test Po0.05): (1) organ and system development; (2) cell
differentiation, migration and development, especially for NCCs
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Figure 1 | Manhattan plots of the P values calculated from the genome-wide association study at the discovery stage. (a) Data were collected from 939
cases with craniofacial microsomia and 2,012 controls on 792,342 SNPs that had passed the quality control. The  log10(logistic regression P value) of
each SNP is shown as a function of genomic position on the autosomes (hg19). Genome-wide signiﬁcance (solid red line; Pr6.3 10 8) and suggestive
signiﬁcance (solid blue line; Pr1 10 5) are denoted. (b–h) Regional plots shows the association of craniofacial microsomia risk with all signiﬁcant loci,
continuous genomic regions surrounding the lead SNPs, including 2p21 (b), 2q37.2 (c), 3p12.3 (d), 10p14 (e), 11q13.3 (f), 13q22.1 (g) and 15q24.1 (h).
Each point represents a SNP plotted with its  log10P value as a function of genomic position (hg19). Imputation analysis is shown with circles and direct
genotyping with squares. In each regional plot, the purple symbol denotes the lead SNP, showing its name on the top of each plot. The colour coding of the
rest of the SNPs showed in LD with the lead SNP: red, r2Z0.8; gold, 0.6rr2o0.8; green, 0.4rr2o0.6; cyan, 0.2rr2o0.4; blue, r2o0.2; grey, r2 unknown.
Recombination rates were estimated from ASN population of 1KG project (Mar 2012). Gene annotations were taken from the UCSC genome browser.
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and mesenchymal cell; (3) vasculature development; and
(4) regulation of phosphorus metabolic process. We used
pairwise kappa similarity between terms from these four
clusters to show their network structures (Fig. 2). We found the
four clusters of biological processes correlated with each other.
Many terms within the four clusters are relevant to the progresses
of embryonic development, noting that the differentiation and
migration of NCCs and mesenchymal cells play paramount roles
in craniofacial morphogenesis.
To further explore the CFM candidate genes and their
expression patterns, we analysed the 13 associated loci with
the Data-Driven Expression-Prioritized Integration for Complex
Traits (DEPICT) tool16. This analysis showed that 11 signiﬁcantly
prioritized genes (SHROOM3, DCAKD, NID2, PARD3B, ROBO1,
ARID3B, KLF12, FGF3, EPAS1, EDNRB, FRMD4A; with a false
discovery rateo5%) had functional connections (Supplementary
Data 8). Gene set enrichment analyses identiﬁed the enriched
categories of ‘positive regulation of cell differentiation,’ ‘abnormal
neural tube morphology,’ and ‘failure of initiation of embryo
turning’ from those genes. Tests of enrichment of expression in
particular tissues and cell types further identiﬁed 25 signiﬁcant
categories (t-test P-valueo0.05), including 3 entries from the
cardiovascular system, 6 from the musculoskeletal system, 6 from
stem cells and 4 from the connective tissue cells (Supplementary
Fig. 6). These signiﬁcant categories were closely related to each
other and critical for embryonic development.
Gene expression patterns in embryos and gene-editing mice.
To investigate the expression patterns of our candidate genes in
embryos, we interrogated the in situ hybridization data from the
gene expression database of the Mouse Genome Informatics,
the Gallus Expression in situ Hybridization Analysis, and the
Xenbase. All the candidate genes were expressed in the above
database, and 10 of them were expressed in pharyngeal arches
from where the craniofacial structures developed (Supplementary
Fig. 7 and Data 9). It is notable that all the candidates expressed
in the CFM-inﬂuenced organs during embryogenesis, such as
cranial ganglion, mandible and sensory organs of ear and eye.
Considering that all studied CFM patients had external ear
malformation, we measured the expression levels of the candidate
genes of ROBO1, EPAS1, KLF12, SHROOM3, NRP2, EDNRB,
ARID3B, SEMA7A, PLCD3, FGF3 and GBX2 by quantitative
reverse transcription–PCR using the external ear tissues of
BALB/c mice at 18 d.p.c. (days post coitum), 0 d.p.n. (days
postnatal), 5 d.p.n. and adult. The results showed that mRNAs of
ROBO1, EPAS1, KLF12, SHROOM3, NRP2, SEMA7A and EDNRB
were detectable in the external ear of these four stages of mice
development (Supplementary Fig. 8).
To understand the phenotypic consistency between CFM
and mutant mouse models of the candidate genes, we
interrogated the phenotypes of gene-editing mice deposited in
the database of Mouse Genome Informatics. Mutant mice of nine
candidate genes (ROBO1, GATA3, GBX2, FGF3, NRP2, EDNRB,
SHROOM3, SEMA7A and ARID3B) were characterized by
malformations of craniofacial system (Supplementary Fig. 7 and
Data 10). Many mutant mice even shared similar phenotypes
with CFM, such as abnormal craniofacial bone morphology,
abnormal ear development and abnormal cranial ganglia
Table 1 | Most signiﬁcantly associated risk variants with craniofacial microsomia.
Chr. (band) Lead SNPs Position Alleles GWAS (939 versus 2,012)* Replication (443 versus 1,669)* Combined (1,382 versus 3,681)*
P OR (95% CI) P OR (95% CI) Freq. P OR (95% CI)
Genome-wide signiﬁcant loci for all cases
2p21 rs17802111 46509657 A/G 1.44 10 11 1.48 (1.32–1.66) 5.45 10 7 1.47 (1.26–1.71) 0.46 9.57 10 18 1.48 (1.35–1.62)
2q33.3 rs7420812 206435709 G/A 2.01 106 1.33 (1.18–1.49 ) 1.32 104 1.35 (1.16–1.58) 0.37 6.74 10 10 1.33 (1.22–1.46)
2q37.2 rs3754648 237021346 A/G 6.33 10 9 1.41 (1.26–1.58) 2.53 10 5 1.38 (1.19–1.61) 0.42 5.09 10 13 1.39 (1.27–1.53)
3p12.3 rs13089920 78552232 G/A 1.06 10 70 5.21 (4.34–6.25) 2.62 1046 5.05 (4.05–6.31) 0.25 2.15 10 120 5.18 (4.51–5.95)
10p14 rs10905359 8449891 A/C 6.58 10 9 0.71 (0.63–0.80) 2.98 10 3 0.79 (0.68–0.92) 0.33 5.11 10 9 0.76 (0.69–0.83)
11q13.3 rs11263613 69661334 A/G 7.91 10 12 1.71 (1.47–2.00) 5.44 106 1.60 (1.31–1.96) 0.19 3.61 10 17 1.68 (1.49–1.89)
15q24.1 rs10459648 74865440 A/G 2.86 10 12 0.67 (0.59–0.75) 1.12 10 10 0.60 (0.52–0.70) 0.40 1.05 10 23 0.63 (0.58–0.69)
Genome-wide signiﬁcant locus for left-side-affected cases (case number for GWAS, replication, and combined set was 330, 151 and 481, respectively.)
13q22.1 rs17090300 74157451 A/G 6.26 10 9 2.42 (1.80–3.26) 1.36 10 3 2.04 (1.32–3.15) 1.04 10 11 2.31 (1.81–2.93)
Suggestive signiﬁcant loci with all cases
4q21.1 rs3923380 77468594 C/A 1.05 106 0.75 (0.67–0.84 ) 5.32 10 2 0.86 (0.74–1.00) 0.38 8.19 108 0.78 (0.71–0.86)
10p13 rs4750407 13795471 G/A 3.02 106 1.32 (1.18–1.49) 2.69 10 2 1.19 (1.02–1.39) 0.36 2.49 10 7 1.27 (1.16–1.40)
13q22.3 rs9574113 78418131 G/A 4.12 106 0.73 (0.64–0.84 ) 8.62 10 2 0.86 (0.72–1.02) 0.22 8.16 106 0.79 (0.71–0.88)
14q22.1 rs754423 52527187 G/A 4.14 10 7 1.32 (1.18–1.47 ) 2.32 10 2 1.19 (1.02–1.37) 0.53 1.19 10 7 1.27 (1.16–1.38)
17q21.31 rs7222240 43136195 A/G 6.13 106 2.01 (1.48–2.75 ) 1.05 10 1 1.39 (0.93–2.08) 0.04 9.49 10 6 1.73 (1.36–2.20)
Varexpl (%) Het
Pvalue
Nearby genes Candidate genes
GRAIL DEPICT NCC related
0.7849 0.6134 PRKCE, EPAS1, TCONS_00004241 EPAS1 EPAS1 EPAS1
0.4283 0.7895 FARD3B, NRP2 PARD3B PARD3B NRP2
0.7219 0.5576 ASB18, AGAP1, GBX2 GBX2 — GBX2
2.1512 0.3708 ROBO1 ROBO1 ROBO1 ROBO1
0.6334 0.2967 LINC00708, GATA3, GATA3-AS GATA3 — GATA3
0.9065 0.2718 CCND1, FGF19, ORAOV1, FGF3, FGF4, TCONS_00019371 FGF3 FGF3 FGF3
0.3886 0.9419 SEMA7A, UBL7, ARID3B, CLK3, EDC3, CCDC33, CYP11A1, TCONS_00023466 SEMA7A ARID3B ARID3B, SEMA7A
0.9065 0.13 KLF12, TCONS_00021669, TCONS_00021670, TCONS_I2_00006907, TCONS_I2_00007425 KLF12 KLF12 KLF12
0.3657 0.07134 FLJ25770, SHROOM3 SHROOM3 SHROOM3 SHROOM3
0.6429 0.1577 FRMD4A, PRPF18 FRMD4A FRMD4A —
0.4057 0.1425 SLAIN1, EDNRB, SCEL, LINC00446, LINC01069 EDNRB EDNRB EDNRB
0.3904 0.1554 NID2, GNG2, TCONS_00022504, TCONS_00022745,C14orf166 C14orf166 NID2 —
0.158 0.09706 ACBD4, CCDC103, KIF18B, PLCD3, HEXIM1, DCAKD, GFAP, FMNL1, HEXIM2, NMT1, C1QL1, C17orf46,
EFTUD2
PLCD3 DCAKD PLCD3
Chr. (band), cytogenetic band; CI, conﬁdence interval; DEPICT, candidate genes predicted by DEPICT; Freq., frequency of the effect allele in cases; nearby genes, genes (including LincRNAs (large
intergenic non-coding RNAs)) spanning or ﬂanking (o200-kb away from) the lead SNP from UCSC genome browser; GRAIL, candidate genes predicted by GRAIL; GWAS, genome-wide association
study; NCC; neural crest cell; OR, odds ratio for the minor allele; Position, physical position of human genome version of hg19; SNP, (single-nucloetide polymorphism) rsID of the lead variant; Varexpl,
variance in liability to microtia explained by the locus at the prevalence rate of 1.4/10,000 in China.
*The former is for cases number and the latter is for controls number.
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morphology, which indicated the involvement of the candidate
genes in the development of craniofacial structure.
WGS on 21 CFM patients. To identify the potential causal
mutations within the 13 associated loci, we performed WGS on
21 selected CFM patients from our study. We focused on novel
mutations (not documented in dbSNP 138) of the following
types: missense, frameshift, splice-donor and stop-gained. Finally,
we obtained 40 missense and 2 frameshift mutations within 1-Mb
genomic region surrounding the lead SNPs, and 20 of them had a
PolyPhen score 40.6 (Supplementary Data 11). Supplementary
Data 12 illustrates the potentially functional novel mutations in
the CFM candidate genes. For 4 of the 21 patients, each had a
novel missense mutation in GATA3, SHROOM3, KLF12 and
PLCD3, separately. Results from the functional analyses indicate
that p.M2R in SHROOM3 and p.A20S in GATA3 are deleterious
to the corresponding protein. p.M20V in KLF12 may modify the
local secondary structure of the protein (Supplementary Fig. 9).
p.R291H in PLCD3 may disrupt an H-bond between amino
acids 291 and 286 (Supplementary Fig. 10), which may change
the energy level (from  281.151 to  14.364) at 291 site and
potentially lead to the instability of local structure.
Discussion
Gestational exposure to teratogens supports the notion that
the environmental factors contribute to CFM. However,
various susceptibility loci identiﬁed from CFM or CFM-related
syndromes indicate the critical involvement of genetics in this
congenital disease3,17. Here we performed the ﬁrst GWAS on
CFM, identifying eight genome-wide signiﬁcant loci and ﬁve
implicated loci, which jointly explain 8.9% of the variance in
susceptibility to this craniofacial anomaly. Several CFM-related
genes or mutations have been proposed. Importantly, the
candidate genes, except FGF3 (ref. 18), within the 13 loci were
newly reported in association with CFM. Our ﬁndings not only
identify new risk loci for CFM, but also imply the complexity of
genetic aetiology of this malformation.
Our results suggest that the candidate genes within the 13
associated loci are strongly correlated with the craniofacial
development. First, the most prominent ﬁnding is that many of
our candidate genes, such as ROBO1, GBX2, NRP2, EDNRB and
FGF19, are functionally connected to each other and involved in
NCCs and mesenchymal cells development and vasculogenesis.
It is well known that craniofacial structures are derived from the
ﬁrst and second pharyngeal arches, which are composed of
mesenchymal cells of cranial neural crest and mesodermal
origin4. Second, the cell type-speciﬁc enrichment analyses based
on the ENCODE or Roadmap projects indicate the enrichment of
CFM-associated variants in regulatory elements of embryonic
stem cells, which implies their potential roles in embryonic
development. Third, in situ hybridization in the embryos of
mouse, chicken and frog demonstrate that many of our candidate
genes, such as ROBO1, FGF3, EPAS1, KLF12, ARID3B, GBX2,
EDNRB and NRP2, are highly expressed in the pharyngeal arches
and their derivatives of CFM-related craniofacial substructures,
such as jaw, ear and eye. Fourth, mutant mice of the candidate
genes frequently exhibit abnormalities at pharyngeal arches and
the craniofacial region19–25. For example, Ednrb or Arid3b
mutant mice have abnormal pharyngeal arch morphology24,25.
Mouse embryos deﬁcient in GBX2 display aberrant migration and
patterning of NCCs through disrupting the Slit/Robo signalling
pathway21,23. Mutations in SHROOM3 lead to cranial neural
tube defects in mice22. Altogether, our ﬁndings reinforce the
involvement of these genes in the pathogenesis of CFM.
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Figure 2 | Graphic display of the similarity among the 25 gene ontology terms and their P values. The P value (Fisher’s exact test) of each term
and kappa similarity among terms were derived from the Database for Annotation, Visualization and Integrated Discovery (DAVID). The 25 nodes
represents 25 gene ontology terms. The P values of the 25 nodes are indicated by the gradations in the colour red. The similarities between them
are indicated by edges scaled according to their correlation (only correlations with a Kappa 40.5 are shown; the correlation are divided into 5 levels
equally from 0.5 to 1) and node size represents connection times among nodes.
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NCCs are generated at the dorsal of the neural tube and
subsequently undergo processes of delamination, transition,
migration, patterning and differentiation into multiple cell types,
which contribute to the formation of peripheral nervous system,
craniofacial cartilage and bones and pigment cells4. Many of
candidate genes identiﬁed in this study participated in all steps of
NCCs development. SHROOM3 plays a critical role in neural tube
closure26. GBX2 activates the expression of ROBO1 involved in
the Slit-Robo signalling that controls the motility and localization
of NCCs27. NRP2 is involved in the Sema-Nrp signalling, which
shapes the NCCs migration streams by marking NC-free
regions28. SEMA7A may also be involved in the Sema-Nrp
signalling due to its widespread expression in cranial NCCs29.
EDNRB is highly expressed in neural crest-derived head
mesenchyme and determines the migration path of NCCs30.
ARID3B and FGF3 encode integrant for the identity, survival and
differentiation of chondrogenic NCCs31,32, and the FGF
signalling is also important for the homing process of NCCs33.
In summary, many of the CFM candidate genes participate in the
migration and differentiation of NCCs, and subsequently affect
the formation of the NCCs-derived craniofacial organs.
NCC development disturbance has been well-accepted in the
pathogenesis of CFM, while the hypothesis of vascular disruption
is also noticeable3. Disruption in the development of the blood
vascular system in an embryo can result in local ischaemia and
birth defects34. In this study, EPAS1 is found as a candidate gene
for CFM. EPAS1 is highly expressed in pharyngeal arches and
vascular endothelial cells to regulate several genes involved in the
development of blood vessels35. Meanwhile, one of the fates of
NCCs is to differentiate into vascular endothelial cells and, later,
to build up the vascular wall4. Although more studies are needed
to reveal the relationship between EPAS1 and NCCs, NCCs
disturbance and vascular disruption may act synergistically to
result in the facial malformation.
Our results signiﬁcantly improve our understanding of the
genetic pathogenesis of CFM. However, further studies are
required to strengthen our ﬁndings. First, future GWAS and
subsequent meta-analysis with world-wide CFM patients are
expected to validate those associated loci, as well as to identify
new ones. Second, deep-sequencing more DNA samples at the
associated loci would help to identify the causative variants
for CFM with next-generation sequencing technologies. Third,
those associated variants mapped to regulatory elements
require functional validation in their relevant cell types, such as
NCCs and stem cell lines. Taken together, our study ﬁnds several
new risk loci for CFM and connects the candidate genes to
biological processes of NCCs migration and differentiation.
The results not only highlight the genetic architecture of CFM,
but also provide new clues for other craniofacial anomalies or
syndromes.
Methods
Samples. We collected 1,382 congenital CFM patients from Plastic Surgery
Hospital of Peking Union Medical College as a case cohort for a GWAS study. The
cohort was composed of 1,056 males and 326 females with a mean age of 11.9 years
old (s.d.: 6.5; range 4–48 years). Most of the patients were presented as a unilateral
anomaly (1,256 individuals, 90.9%), with the right side being affected in nearly
61.7% (775 individuals). More details on phenotypes were illustrated in
Supplementary Data 13. Among them, 1,308 patients had a record of geographic
location and 71% of them were from northern China (using the boundary sug-
gested by Xu et al.36). The control cohort was composed of 3,681 individuals with
2,362 males and 1,319 females, and was collected from several medical examination
centres located in both northern and southern China. The percentage of control
samples from northern China was 69.7%, not signiﬁcantly (two-tailed w2-test
P¼ 0.52) different from that of the case cohort.
All participants signed informed consent forms for biological investigations.
This project was reviewed and approved by the Ethics Committee of the Plastic
Surgery Hospital, Chinese Academy of Medical Sciences and Beijing Institute of
Genomics, Chinese Academy of Sciences, in adherence with the Declaration of
Helsinki Principles.
Genotyping and quality control. All DNA samples were extracted using
DNA-extraction kits (Tiangen Biotech). At the discovery stage, 942 cases and 2,020
controls were randomly loaded in 96-well plates and genotyped with the Human
Omni-Zhonghua chips (Illumina) according to the manufacturer’s speciﬁcations.
Genotyping module of Genomestudio v3.0 (Illumina) was used to call the genotype
of about 0.9 million SNPs. All DNA samples were successfully genotyped at a call
rate 499.7% with a genotype call threshold (boundary for calling genotypes
relative to its associated cluster) of 0.15. The genotype reoccurrence rate for three
duplicated individuals was 99.99% on average.
To obtain high-quality data for GWAS, we pruned the data set of discovery
stage with the following criteria: sample call rate499%; SNP call rate495%; and a
threshold for Hardy–Weinberg equilibrium of 0.0001 (Fisher’s exact test) in control
cohort (Supplementary Fig. 11). In addition, to exclude closely related individuals,
we calculated genome-wide identity by descent (IBD) for each pair of samples.
We found that one pair of case and eight pairs of control have IBD 40.05, and
removed one from each pair for the subsequent analyses. Due to limited power of
rare variants in an association study, we only kept SNPs with minor allele
frequencies 40.01. We extracted genotype data of the Yoruba in Ibadan (YRI),
Utah Residents (CEPH) with Northern and Western European Ancestry (CEU),
Japanese in Tokyo (JPT), Han Chinese in Bejing (CHB) and Southern Han Chinese
(CHS) populations from the 1KG project and performed a principal component
analysis (PCA) on these samples along with our genotyped samples using
smartPCA package37. Asian populations (including CHB, CHS, JPT, and our
samples) were clustered together, while Chinese samples were well separated from
the Japanese samples (Supplementary Fig. 12). All Chinese samples were clustered
into two subgroups, consistent with the notion of two different populations of
northern and southern Chinese. We found that two outliers (based on genome-
wide IBS) existed within our patients and were removed from subsequent analyses.
In the end, we obtained 939 cases and 2,012 controls with 792,342 SNPs for our
GWAS analyses. The total genotyping rate was 99.86%.
Genotyping for the lead SNPs in the 13 loci was done in additional 446 cases
and 1,669 controls using the MassARRAY system from Sequenom. Three samples
with more than 5% missing genotypes were removed from the data analysis.
Fourteen SNPs had less than 5% missing genotypes and showed no deviation from
Hardy–Weinberg equilibrium (P40.05, Fisher’s exact test) in control samples.
Genetic power calculation. We used CaTS38 to estimate the statistical power of
the current sample size. Under a multiplicative model, we set the case number at
942, control number at 2012, and a disease prevalence rate at o0.001, then
estimated the power to obtain a signiﬁcant level of 0.05, 1 10 4 and 5 10 8 at
disease allele frequency (DAF) of 0.1, 0.05 and 0.01, respectively (Supplementary
Fig. 13). Although the power was limited under the current sample size, we still
had 80% chance to obtain genome-wide signiﬁcant SNPs (P¼ 5 10 8, the
Bonferroni-corrected signiﬁcance threshold) with genetic relative risk (GRR)¼ 1.7
and a minor allele frequency¼ 0.1, or GRR¼ 2 and DAF¼ 0.05, or GRR¼ 4 and
DAF¼ 0.01.
Association test. We estimated the associations between SNP genotypes and
CFM traits by applying LRs in Plink (v1.9)39. To handle the population
stratiﬁcation of the samples, we performed LRs on all SNPs with a covariate of the
ﬁrst 20 eigenvectors from PCA. A QQ plot of this test was shown in Supplementary
Fig. 14, of which the genomic inﬂation factor was 1.036 (based on median w2).
The Manhattan plots were constructed using qqman40. Bonferroni adjustment
was corrected for multiple comparisons, and the threshold for genome-wide
signiﬁcance was set at a P value o6.3 10 8 (¼ 0.05/792,342 variants). The
regional association plots and linkage disequilibrium (LD) plots were performed
using LocusZoom41. We performed more conditional LRs on the replicated
samples with the ﬁrst 20 eigenvectors from PCA as covariate and carried out
combined analyses on the discovery and replication data, male versus female
subgroups, left- versus right-side-affected subgroups using METAL42 with the
parameters as follows: EFFECT, Beta; Weights in P value-Based Analysis, sample
size; and heterogeneity, Cochran’s Q-test.
Genotype imputing. Pre-phasing haplotypes of each signiﬁcantly associated locus
was performed by SHAPEIT algorithm43. Imputing the untyped SNPs within a
CFM-associated locus was based on the 1KG project phase 1 integrated variant set
(b37; December 2013) with IMPUTE2 (ref. 44). In order to remove poorly imputed
SNPs, we used a strict cutoff (info of 0.85) for post-imputation SNP ﬁltering. LRs,
controlling for the ﬁrst 20 eigenvectors from PCA, were performed to test for the
associations of imputed variants with CFM.
Conditional association analysis. To identify other independently associated
SNPs at a signiﬁcant locus, we performed a conditional analysis on genotyped and
imputed data using Plink. We ﬁrst conducted association tests on the remaining
signiﬁcant SNPs by adjusting for the most signiﬁcantly one at that locus. We then
repeated the test with adjustment of the most signiﬁcant one plus the remaining
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variants until no further genome-wide signiﬁcant SNPs could be remained.
Independently associated SNPs were those who have P value o0.05 after
Bonferroni’s adjustment in conditional association test.
Joint multiple-SNP analysis for association study. To interrogate the
interactions of SNPs within a gene or a deﬁned haplotype block, we performed
joint analyses. We deﬁned 18,414 gene sets harbouring 358,890 SNPs and 120,458
block sets harbouring 606,013 SNPs. To test for joint effects with SKAT package11,
multiple LR was implemented with the ﬁrst ﬁve eigenvectors of PCA as covariates
and with polyphen scores45 as each SNP’s weight. The thresholds for adjustment
of multiple tests were set at 2.72 10 6 (0.05/18,414 sets) and 4.15 10 8
(0.05/120,458 sets) for gene set and haplotype-set-based regressions, respectively.
Functional annotation. We annotated the CFM-associated variants (typed and
imputed) using SeattleSeq (v138) and HaploReg (v2)12. For SeattleSeq, we just kept
variants that might have functional effects (Supplementary Data 2). For HaploReg,
we only queried variants with a GWAS P value o1 10 4. All the annotations
were displayed in Supplementary Data 3. The LD calculation was based on the ASN
populations from 1KG (phase 1), and LD threshold (r2) was set at 1.0. The
enrichment analyses of enhancer and DNase hypertension site were performed
based on the ENCODE and the Roadmap databases with 1KG ANS pilot data as
background set.
eQTL analysis. To interrogate the associated SNPs with regard to gene expression,
we performed eQTL analyses on SNPs with a GWAS P valueo0.01 using Genevar
(v3.3.0) a platform of database and web services, designed for data integration,
analysis and the visualization of SNP–gene associations13. With a SNP-centric
approach, we used SNP–gene association analyses with genetic variations and gene
expression proﬁling data from lymphoblastoid cell lines of the CEU, CHB, GIH,
JPT, LWK, MEX, MKK and YRI individuals from HapMap. We measured the
effects with the parameters set to Spearman’s rank correlation coefﬁcients and with
a window size of 200-kb and a P value threshold of 0.01. For the seven HapMap
populations, signiﬁcant eQTL SNPs associated with gene expression are illustrated
in Supplementary Data 4.
Estimation of CFM variance explained. We used the GCTA package46 to
estimate the variance in CFM liability, which could be explained by either the
associated SNPs or all genotyped SNPs. The prevalence of CFM was 1.4 per 10,000,
estimated from a 5-year epidemiological study in China10. For each associated
locus, we used a SNP set composed of SNPs with a P value o0.05 in that locus to
estimate the phenotypic variance that could be explained.
Candidate gene prediction and pathway analyses. We used GRAIL14 to analyse
the potential relationships of the residing genes in the 13 associated loci without
phenotype information. The query regions comprised the 200-kb ﬂanking regions
of a lead SNP (if no gene was found, then the nearest gene to that SNP was picked).
The analysis settings were as the following: human genome assembly, HG18;
HapMap population, CHBþ JPT; functional data source, PubMed Text (August
2014); gene size correction, off; gene list, default gene list; queries and seed regions,
equal.
To perform gene-annotation enrichment analyses and functional annotation
clustering, we analysed the 46 genes from GRAIL using the DAVID v6.7 (ref. 15).
Modiﬁed Fisher’s exact test was used to determine the signiﬁcance of gene-term
enrichment. The ES was used to rank the overall enrichment of the annotation
groups. The ES value was deﬁned as minus log transformation on the average
P values of annotation terms and was set at 1.3 (non-log scale of 0.05) for
signiﬁcance. To trim the annotation clusters, we used high-classiﬁcation stringency
parameters set suggested by DAVID. To depict the relationship among gene
ontology terms within a signiﬁcant cluster, we used R language to illustrate the
kappa similarity between the terms.
We also used DEPICT to systematically identify the most likely causal genes in
a CFM-associated locus with regard to the highly expressed tissues and cell typed
and enriched physiological condition47. We ﬁrst retrieved independent 13 sets of
loci using clump methods in Plink (parameters of --clump-p1 1e-5 --clump-kb
500 --clump-r2 0.1). We then submitted them to DEPICT and obtained 13
non-overlapping genomic regions (similar to our previous identiﬁed 13 loci) with a
total of 29 genes. Meanwhile, gene expression level and physiological system
enrichment were also analysed using various databases of gene expression,
protein–protein interactions, Mouse Genetics Initiative, Gene Ontology and
pathways of Reactome and KEGG.
Gene expression in embryos and gene-editing mice. To investigate the
expression pattern of the candidate genes in embryos, we interrogated in situ
hybridization data of ROBO1, GATA3, GBX2, FGF3, NRP2, EDNRB, SHROOM3,
SEMA7A, EPAS1, KLF12, PLCD3 and ARID3B using the database of Mouse
Genome Informatics, Gallus Expression in situ Hybridization Analysis and
Xenbase. We focused on the NCCs-related tissues and CFM-inﬂuenced facial
substructures. To explore the phenotypes of mutant mice caused by these candidate
genes, we interrogated the database of Mouse Genome Informatics and focused on
embryonic substructures that related to the craniofacial development.
External ear’s malformation was a common character to CFM. The
development of external ears is completed at 5 d.p.n. for mouse. We collected the
external ears from BALB/c lineage at 18 d.p.c. (3 samples, 1 male and 2 females),
0 d.p.n. (3 samples, 2 males and 1 female), 5 d.p.n. (3 samples, 2 male and 1
females) and adult (4 samples, 3 males and 1 females), respectively. Frozen tissues
were disrupted and homogenized in RLT Buffer. Total RNA was extracted from the
ear tissue samples with the traditional TRIzol method, quantiﬁed with a Nanodrop
spectrophotometer (Thermo Fisher Scientiﬁc). The quality of RNA was conﬁrmed
with agarose electrophoresis. The total RNA was reverse transcribed into
complementary DNA (cDNA) in a 20-ml reaction using a FastQuant RT Kit
(YQYK-biotech). For quantitative reverse transcription–PCR ampliﬁcations,
gene-speciﬁc primers for ROBO1, ARID3B, SEMA7A, FGF3, FGF4, EPAS1, KLF12,
GBX2, SHROOM3, NRP2, EDNRB and PLCD3 were from Sangon-biotech
(Supplementary Table 3). A genomic quantitative real-time PCR was performed
with the 7500 Real-Time PCR system (Applied Biosystems). In a 10 ml PCR
reaction, 5 ml of SYBR Green Master mix (Applied Biosystems), 30 ng of cDNA,
and 10 pmol of each primer were included. The expression level of GAPDH was
measured in parallel as an internal control for normalization. Ampliﬁcation
efﬁciency was conﬁrmed by melt curve analysis demonstrating the absence of
nonspeciﬁc products or primer-dimers. Three replicates were performed for each
biological sample at the reverse transcription step and the same batch of cDNA
was used for all subsequent PCR ampliﬁcations. The relative expression level
was determined using the 2DCt method48. This experiments was reviewed
and approved by the Ethics Committee of the Plastic Surgery Hospital, Chinese
Academy of Medical Sciences, in adherence with the Declaration of Helsinki
Principles.
Whole-genome sequencing. We sequenced the whole genome of 21 CFM
patients from our study samples, including 7 left-side-affected, 7 right-side-affected
and 7 bilateral individuals. The selected individuals were those who had risk alleles
(with a frequency greater in cases than in controls) of the lead SNPs rs17802111,
rs3754648, rs13089920, rs10905359, rs11263613 and rs10459648 for right-side-
affected CFM, rs13089920, and rs17090300 for left-side-affected CFM, and
rs13089920 for bilateral CFM. Paired-end sequencing with 150-bp read lengths was
performed on Illumina HiSeq X10 instrument and yielded a mean depth of 27 .
All reads were mapped to the human reference genome (hg19) using BWA49
(version 0.7.5a). PCR duplicates were removed using the Picard software program
(version 1.92; http://broadinstitute.github.io/picard/). The Samtools50 (version
0.1.19) and GATK51 (version 3.1) software packages were used to call variants.
Within the 13 associated loci, we annotated variants with SeattleSeq Annotation
138 and removed variants that had been reported in dbSNP 138. Then we focused
on the missense, frameshift, splicing and conserved (GERP score42 or phastCons
score 40.8) variants, as well as variants in TFBSs. All variants in Supplementary
Data 11 pass manual conﬁrmation using the IGV package52.
Functional analyses on variants. We performed functional analyses on all
identiﬁed candidate variants with following steps. First, we evaluated possible
impacts of the mutations on the structures or functions of the corresponding
proteins using Polyphen-2 (ref. 53) and SIFT54. Mutations with PloyPhen score
40.5, or SIFT score o0.05 were considered as deleterious to the function or
structure of protein. Second, SignalP 4.1 was used to predict the signal peptide with
the assumption that the protein contained no transmembrane segments55. The
parameters for analysis with SignalP were as follows: Organism group, Eukaryotes;
D-cutoff values (optimize the performance and affect sensitivity), Default; Method,
Input sequences do not include transmembrane segments. Third, we predicted the
secondary structure of both the wild-type and mutant proteins using an online
software PSIPRED (v3.3)56. Fourth, we used SWESS-MODEL to predict the
tertiary structure of each protein and found that mutations were not in any
range of modelled residues except p.R291H in PLCD3. We searched the
three-dimensional (3D) structure deposited in the Research Collaboratory for
Structural Bioinformatics Protein Data Bank (RCSB PDB). We found that only
GATA3 had X-ray-derived 3D structure, but p.A20S in GATA3 was not in the
fragment of unknown structure. Fifth, based on modelled 3D structure of PLCD3,
we used Swiss-PdbViewer 4.1 (ref. 57) to view the effect of p.R291H on the protein
PLCD3. We downloaded Q8N3E9-PLCD3 protein from SWISS-MODEL
repository and analysed the wild-type and mutant proteins using parameters as
follows: minimum energy, residues within six angstroms to the p.R291H, secondary
structure as ribbon format, colourful secondary structure by types, computing
H-bonds and van der Waals.
References
1. Birgfeld, C. B. & Heike, C. Craniofacial microsomia. Semin. Plast. Surg. 26,
91–104 (2012).
2. Birgfeld, C. B. et al. A phenotypic assessment tool for craniofacial microsomia.
Plast. Reconstr. Surg. 127, 313–320 (2011).
3. Luquetti, D. V., Heike, C. L., Hing, A. V., Cunningham, M. L. & Cox, T. C.
Microtia: Epidemiology and genetics. Am. J. Med. Genet. A 158A, 124–139
(2011).
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms10605 ARTICLE
NATURE COMMUNICATIONS | 7:10605 | DOI: 10.1038/ncomms10605 | www.nature.com/naturecommunications 7
4. Trainor, P. A. Neural crest cells: evolution, development and disease (2013).
5. Friedman, L. M., Dror, A. A. & Avraham, K. B. Mouse models to study inner
ear development and hereditary hearing loss. Int. J. Dev. Biol. 51, 609–631
(2007).
6. Husain, T., Langlois, P. H., Sever, L. E. & Gambello, M. J. Descriptive
epidemiologic features shared by birth defects thought to be related to vascular
disruption in Texas, 1996-2002. Birth Defects Res. A Clin. Mol. Teratol. 82,
435–440 (2008).
7. Van Bennekom, C. M., Mitchell, A. A., Moore, C. A. & Werler, M. M.
Vasoactive exposures during pregnancy and risk of microtia. Birth Defects Res.
A Clin. Mol. Teratol. 97, 53–59 (2013).
8. Alasti, F. & Van Camp, G. Genetics of microtia and associated syndromes.
J. Med. Genet. 46, 361–369 (2009).
9. Ma, C., Carmichael, S. L., Scheuerle, A. E., Canﬁeld, M. A. & Shaw, G. M.
Association of microtia with maternal obesity and periconceptional folic acid
use. Am. J. Med. Genet. A 152A, 2756–2761 (2010).
10. Zhu, J., Wang, Y., Liang, J. & Zhou, G. [An epidemiological investigation of
anotia and microtia in China during 1988-1992]. Zhonghua Er Bi Yan Hou Ke
Za Zhi 35, 62–65 (2000).
11. Wu, M. C. et al. Rare-variant association testing for sequencing data with the
sequence kernel association test. Am. J. Hum. Genet. 89, 82–93 (2011).
12. Ward, L. D. & Kellis, M. HaploReg: a resource for exploring chromatin states,
conservation, and regulatory motif alterations within sets of genetically linked
variants. Nucleic Acids Res. 40, D930–D934 (2012).
13. Yang, T. P. et al. Genevar: a database and Java application for the analysis and
visualization of SNP-gene associations in eQTL studies. Bioinformatics 26,
2474–2476 (2010).
14. Raychaudhuri, S. et al. Identifying relationships among genomic disease
regions: predicting genes at pathogenic SNP associations and rare deletions.
PLoS Genet. 5, e1000534 (2009).
15. Huang, da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative
analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc.
4, 44–57 (2009).
16. Pers, T. H. et al. Biological interpretation of genome-wide association studies
using predicted gene functions. Nat. Commun. 6, 5890 (2015).
17. Li, X. et al. Genome-wide linkage study suggests a susceptibility locus for
isolated bilateral microtia on 4p15.32-4p16.2. PLoS ONE 9, e101152 (2014).
18. Tekin, M. et al. Homozygous FGF3 mutations result in congenital deafness with
inner ear agenesis, microtia, and microdontia. Clin. Genet. 73, 554–565 (2008).
19. Pandolﬁ, P. P. et al. Targeted disruption of the GATA3 gene causes severe
abnormalities in the nervous system and in fetal liver haematopoiesis. Nat.
Genet. 11, 40–44 (1995).
20. Iwata, T., Li, C. L., Deng, C. X. & Francomano, C. A. Highly activated Fgfr3
with the K644M mutation causes prolonged survival in severe dwarf mice.
Hum. Mol. Genet. 10, 1255–1264 (2001).
21. Byrd, N. A. & Meyers, E. N. Loss of Gbx2 results in neural crest cell patterning
and pharyngeal arch artery defects in the mouse embryo. Dev. Biol. 284,
233–245 (2005).
22. Das, D. et al. The interaction between Shroom3 and Rho-kinase is required for
neural tube morphogenesis in mice. Biol. Open 3, 850–860 (2014).
23. Roeseler, D. A. et al. Elongation factor 1 alpha1 and genes associated with
Usher syndromes are downstream targets of GBX2. PLoS ONE 7, e47366 (2012).
24. Sato, T. et al. Recombinase-mediated cassette exchange reveals the selective use
of Gq/G11-dependent and -independent endothelin 1/endothelin type A receptor
signaling in pharyngeal arch development. Development 135, 755–765 (2008).
25. Takebe, A. et al. Microarray analysis of PDGFR alphaþ populations in ES cell
differentiation culture identiﬁes genes involved in differentiation of mesoderm
and mesenchyme including ARID3b that is essential for development of
embryonic mesenchymal cells. Dev. Biol. 293, 25–37 (2006).
26. Lee, C., Le, M. P. & Wallingford, J. B. The shroom family proteins play broad
roles in the morphogenesis of thickened epithelial sheets. Dev. Dyn. 238,
1480–1491 (2009).
27. Giovannone, D. et al. Slits affect the timely migration of neural crest cells via
Robo receptor. Dev. Dyn. 241, 1274–1288 (2012).
28. Schwarz, Q., Vieira, J. M., Howard, B., Eickholt, B. J. & Ruhrberg, C. Neuropilin
1 and 2 control cranial gangliogenesis and axon guidance through neural crest
cells. Development 135, 1605–1613 (2008).
29. Bao, Z. Z. & Jin, Z. Sema3D and Sema7A have distinct expression patterns in
chick embryonic development. Dev. Dyn. 235, 2282–2289 (2006).
30. Harris, M. L., Hall, R. & Erickson, C. A. Directing pathﬁnding along the
dorsolateral path—the role of EDNRB2 and EphB2 in overcoming inhibition.
Development 135, 4113–4122 (2008).
31. Kobayashi, K., Era, T., Takebe, A., Jakt, L. M. & Nishikawa, S. ARID3B induces
malignant transformation of mouse embryonic ﬁbroblasts and is strongly
associated with malignant neuroblastoma. Cancer Res. 66, 8331–8336 (2006).
32. David, N. B., Saint-Etienne, L., Tsang, M., Schilling, T. F. & Rosa, F. M.
Requirement for endoderm and FGF3 in ventral head skeleton formation.
Development 129, 4457–4468 (2002).
33. Trokovic, N., Trokovic, R. & Partanen, J. Fibroblast growth factor signalling
and regional speciﬁcation of the pharyngeal ectoderm. Int. J. Dev. Biol. 49,
797–805 (2005).
34. Sadler, T. W. & Rasmussen, S. A. Examining the evidence for vascular
pathogenesis of selected birth defects. Am. J. Med. Genet. A 152A, 2426–2436
(2010).
35. Takeda, N. et al. Endothelial PAS domain protein 1 gene promotes angiogenesis
through the transactivation of both vascular endothelial growth factor and its
receptor, Flt-1. Circ. Res. 95, 146–153 (2004).
36. Xu, S. et al. Genomic dissection of population substructure of Han Chinese
and its implication in association studies. Am. J. Hum. Genet. 85, 762–774
(2009).
37. Patterson, N., Price, A. L. & Reich, D. Population structure and eigenanalysis.
PLoS Genet. 2, e190 (2006).
38. Skol, A. D., Scott, L. J., Abecasis, G. R. & Boehnke, M. Joint analysis is more
efﬁcient than replication-based analysis for two-stage genome-wide association
studies. Nat. Genet. 38, 209–213 (2006).
39. Purcell, S. et al. PLINK: a tool set for whole-genome association and
population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575 (2007).
40. Turner, S. D. qqman: an R package for visualizing GWAS results using Q-Q
and manhattan plots. bioRxiv doi: 10.1101/005165 (2014).
41. Pruim, R. J. et al. LocusZoom: regional visualization of genome-wide
association scan results. Bioinformatics 26, 2336–2337 (2010).
42. Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efﬁcient meta-analysis of
genomewide association scans. Bioinformatics 26, 2190–2191 (2010).
43. Delaneau, O., Zagury, J. F. & Marchini, J. Improved whole-chromosome
phasing for disease and population genetic studies. Nat. Methods 10, 5–6
(2013).
44. Howie, B. N., Donnelly, P. & Marchini, J. A ﬂexible and accurate genotype
imputation method for the next generation of genome-wide association studies.
PLoS Genet. 5, e1000529 (2009).
45. Ramensky, V., Bork, P. & Sunyaev, S. Human non-synonymous SNPs:
server and survey. Nucleic Acids Res. 30, 3894–3900 (2002).
46. Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: a tool for
genome-wide complex trait analysis. Am. J. Hum. Genet. 88, 76–82 (2011).
47. Geller, F. et al. Genome-wide association analyses identify variants in
developmental genes associated with hypospadias. Nat. Genet. 46, 957–963
(2014).
48. Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using
real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25,
402–408 (2001).
49. Li, H. & Durbin, R. Fast and accurate long-read alignment with
Burrows-Wheeler transform. Bioinformatics 26, 589–595 (2010).
50. Manolio, T. A. Cohort studies and the genetics of complex disease. Nat. Genet.
41, 5–6 (2009).
51. DePristo, M. A. et al. A framework for variation discovery and genotyping
using next-generation DNA sequencing data. Nat. Genet. 43, 491–498
(2011).
52. Thorvaldsdottir, H., Robinson, J. T. & Mesirov, J. P. Integrative Genomics
Viewer (IGV): high-performance genomics data visualization and exploration.
Brief Bioinform. 14, 178–192 (2012).
53. Adzhubei, I. A. et al. A method and server for predicting damaging missense
mutations. Nat. Methods 7, 248–249 (2010).
54. Kumar, P., Henikoff, S. & Ng, P. C. Predicting the effects of coding
non-synonymous variants on protein function using the SIFT algorithm.
Nat. Protoc. 4, 1073–1081 (2009).
55. Petersen, T. N., Brunak, S., von Heijne, G. & Nielsen, H. SignalP 4.0:
discriminating signal peptides from transmembrane regions. Nat. Methods 8,
785–786 (2011).
56. McGufﬁn, L. J., Bryson, K. & Jones, D. T. The PSIPRED protein structure
prediction server. Bioinformatics 16, 404–405 (2000).
57. Johansson, M. U., Zoete, V., Michielin, O. & Guex, N. Deﬁning and searching
for structural motifs using DeepView/Swiss-PdbViewer. BMC Bioinformatics
13, 173 (2012).
Acknowledgements
This study was supported by grants from the National Natural Science Foundation of
China (31201006, 31371347 to Y-B.Z.; 81372085, 81571924 to Q.Z.; and 81300863 to
J.H.). The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Author contributions
Y-B.Z., Q.Z. and X.D. designed the study. Q.Z., J.H., J.Z., T.L., Y.X., J.Q. and Y.W.
recruited case samples and J.Z., J.L., X.L. and M.G. recruited control samples. J.H.,
J.Z., P.W. and T.W. planned and conducted laboratory experiments. Y-B.Z. and C.G.
performed bioinformatics and statistical analyses. Y-B.Z., X.D., J.Y. and Q.Z. drafted and
revised the manuscript. All the authors reviewed and contributed to the manuscript.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms10605
8 NATURE COMMUNICATIONS | 7:10605 | DOI: 10.1038/ncomms10605 | www.nature.com/naturecommunications
Additional information
Accession codes: The craniofacial microsomia chips data have been deposited in GEO
under the accession codes GSE69664. The craniofacial microsomia WGS data have been
deposited in SRA under the accession codes SRP067380.
Supplementary Information accompanies this paper at http://www.nature.com/
naturecommunications
Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
How to cite this article: Zhang, Y.-B. et al. Genome-wide association study identiﬁes
multiple susceptibility loci for craniofacial microsomia. Nat. Commun. 7:10605
doi: 10.1038/ncomms10605 (2016).
This work is licensed under a Creative Commons Attribution 4.0
International License. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated otherwise
in the credit line; if the material is not included under the Creative Commons license,
users will need to obtain permission from the license holder to reproduce the material.
To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms10605 ARTICLE
NATURE COMMUNICATIONS | 7:10605 | DOI: 10.1038/ncomms10605 | www.nature.com/naturecommunications 9
